REQUEST A DEMO
Total
USD $0.00
Search more companies

Trial Pharma Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Trial Pharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Trial Pharma Kft. is based in Hungary. The head office is in Puspokladany. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The enterprise was incorporated on December 01, 2015. 3 (2024) employees currently work for Trial Pharma Kft.. From the latest financial highlights, Trial Pharma Kft. reported a net sales revenue increase of 158.38% in 2023. Over the same period, its total assets grew by 109.25%. In 2023, Trial Pharma Kft.’s net profit margin increased by 27.47%.

Headquarters
Kossuth utca 1.
Puspokladany; Hajdu-Bihar; Postal Code: 4150

Contact Details: Purchase the Trial Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Trial Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Trial Pharma Kft. report to view the information.
Incorporation Date:
December 01, 2015
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Trial Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
158.38%
Total operating revenue
151%
Operating profit (EBIT)
835.1%
EBITDA
707.15%
Net Profit (Loss) for the Period
843.99%
Total assets
109.25%
Total equity
305.74%
Operating Profit Margin (ROS)
30.16%
Net Profit Margin
27.47%
Return on Equity (ROE)
55.71%
Quick Ratio
2.88%
Cash Ratio
1.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?